
Please try another search
Staidson (Beijing) BioPharmaceuticals Co., Ltd. primarily engages in the research and development, production, and marketing of therapeutic and biological drugs in China. The company offers protein drugs, including therapeutic monoclonal antibody drugs; chemical drugs; and drugs for urinary, intestinal, infectious, autoimmune, nervous system, and other diseases. Its product portfolio includes Mouse Nerve Growth factor for injection, Compound Polyethylene Glycol Electrolyte Powder (IV), Troponium Chloride Capsules, Gliclazide extended-release tablets, Aspirin enteric-coated tablets, Compound polyethylene glycol (3350) electrolyte oral solution, Compound polyethylene glycol (3350) electrolyte vitamin C. Staidson (Beijing) BioPharmaceuticals Co., Ltd. was founded in 2002 and is based in Beijing, China.
Name | Age | Since | Title |
---|---|---|---|
Zhi Wen Zhou | 60 | 2009 | Chairman |
Hongshan Zhang | 61 | 2018 | Chairman of Supervisory Board |
Tao Li | 62 | 2011 | Supervisor |
Rong Qin Zhang | 57 | 2013 | Non-Independent Director |
Li Zhao | 68 | 2021 | Independent Director |
Jiajun Zhao | 64 | 2021 | Independent Director |
Hong Zheng | 54 | 2021 | Employee Supervisor |
Xiaoyan Wang | 49 | 2022 | Director |
Lianchun Yang | 60 | 2021 | Non-Independent Director |
Qishun Lu | 55 | 2024 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review